Credit rating agency, Credit Analysis & Research (CARE) has revised rating of Sharon Bio-Medicine’s (SBML) long term bank facilities worth Rs 400 crore to ‘BBB-’ from ‘BB+’. The rating agency has revised rating of company’s short term bank facilities worth Rs 25.32 crore to ‘A3’ from ‘A4+’. Moreover, the rating agency has also revised rating of company’s Long Term Loans worth Rs 121.31 crore to ‘BBB-’ from ‘BB+’.
The ratings revision takes into account improvement in financial risk profile of the company post restructuring of FCCBs, robust sales growth in FY13, stable profitability margins of SBML and addition of new capacities towards its formulations division. The ratings also derive strength from SBML’s experienced promoters and international accreditations of its facilities.
Sharon Bio-Medicine’s Toxicology Laboratories is an independent cost centre and is approved by Department of Science & Technology, Government of India. Government of India has approved Good Laboratory Certificate to SA-FORD which is valid as per OECD Countries - GLP studies.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1622.00 |
| Dr. Reddys Lab | 1316.20 |
| Cipla | 1287.00 |
| Zydus Lifesciences | 931.00 |
| Lupin | 2278.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: